Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inotrope, Lusitrope, and Pressor Use in Neonates

Journal of Perinatology volume 25, pages S28–S30 (2005)Cite this article

Abstract

Successful management of neonatal shock is driven by the etiology and pathophysiology of the cardiovascular compromise. In the clinical practice, however, we only have a limited ability to recognize the etiology of the condition (hypovolemia, myocardial dysfunction or abnormal vasoregulation). Therefore, management is based on administration of fluid boluses and vasoactive medications according to personal preference rather than to the underlying pathophysiology. In addition, although management strategies aimed at improving systemic blood pressure may have been associated with a decrease in mortality in critically ill neonates, there are no prospective data on the effect of these management strategies on morbidity, especially on long-term neurodevelopmental outcome. This paper briefly reviews some of the more frequently encountered clinical presentations of neonatal shock and describes the developmentally regulated cardiovascular responses to the pathophysiology-driven management strategies used in these clinical presentations in the critically ill preterm and term neonate.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Seri I . Cardiovascular, renal, and endocrine actions of dopamine in neonates and children. J Pediatr 1995;126:333–344.

    Article  CAS  Google Scholar 

  2. Noori S, Friedlich P, Seri I . Cardiovascular and renal effects of dobutamine in the neonate. NeoReviews 2004;5 (11):E22–E26.

    Article  Google Scholar 

  3. Noori S, Friedlich P, Seri I . Pathophysiology of neonatal shock. In: Polin RA, Fox WW, Abman S, editors. Fetal and Neonatal Physiology. 3rd ed. Philadelphia, PA: WB Saunders Co.; 2003. p. 772–782.

    Google Scholar 

  4. Seri I, Evans J . Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr 2001;13:116–123.

    Article  CAS  Google Scholar 

  5. Seri I, Abassi S, Wood DC, Gerdes JS . Effect of dopamine on regional blood flows in sick preterm infants. J Pediatr 1998;133:728–734.

    Article  CAS  Google Scholar 

  6. Kluckow M, Evans N . Superior vena cava flow in preterm infants: a novel marker of systemic blood flow. Arch Dis Child 2000;82:F182–F187.

    Article  CAS  Google Scholar 

  7. Kluckow M, Evans N . Low superior vena flow and intraventricular haemorrhage in preterm infants. Arch Dis Child 2000;82:F188–F194.

    Article  CAS  Google Scholar 

  8. Osborn D, Evans N, Kluckow M . Randomised trial of dopamine and dobutamine in preterm infants with low systemic blood flow. J Pediatr 2002;140:183–191.

    Article  CAS  Google Scholar 

  9. Nuntnarumit P, Yang W, Bada-Ellzey HS . Blood pressure measurements in the newborn. Clin Perinatol 1999;26:981–996.

    Article  CAS  Google Scholar 

  10. Kissack CM, Carr R, Wardle SP, Weindling AM . Cerebral fractional oxygen extraction in very low birth weight infants is high when there is low left ventricular output and hypocarbia but is unaffected by hypotension. Pediatr Res 2004;55:400–405.

    Article  Google Scholar 

  11. Hausdorff WP, Caron MG, Lefkowitz RJ . Turning off the signal: desensitization of β-adrenergic receptors. FASEB J 1990;4:2881–2890.

    Article  CAS  Google Scholar 

  12. Watterberg KL, Gerdes JS, Gifford KL, Lin HM . Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999;104:1258–1263.

    Article  CAS  Google Scholar 

  13. Seri I, Tan R, Evans J . The effect of hydrocortisone on blood pressure in preterm neonates with pressor-resistant hypotension. Pediatrics 2001;107:1070–1074.

    Article  CAS  Google Scholar 

  14. Knowles RG, Salter M, Brooks S, Moncada S . Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043–10047.

    Article  Google Scholar 

  15. Garland S, Alex CP, Pauly TH, et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999;104:91–99.

    Article  CAS  Google Scholar 

  16. Watterberg KL . Prophylaxis of early adrenal insufficiency to prevent BPD: multicenter trial. Pediatr Res. 55:465A.

Download references

Author information

Authors and Affiliations

  1. Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    Istvan Seri MD, PhD

Authors
  1. Istvan Seri MD, PhD
    View author publications

    Search author on:PubMed Google Scholar

Additional information

Disclosure: IS is a Consultant for DEY, L.P.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seri, I. Inotrope, Lusitrope, and Pressor Use in Neonates. J Perinatol 25 (Suppl 2), S28–S30 (2005). https://doi.org/10.1038/sj.jp.7211316

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.jp.7211316

This article is cited by

Search

Advanced search

Quick links